Clinical Trial Update: Intrathecal Pemetrexed for SCLC Patients With Refractory Brain Metastases or Leptomeninges Metastatic [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intrathecal pemetrexed for small-cell lung cancer patients with refractory brain metastases or leptomeningeal metastasis; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Small-cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING